CD274 and Merkel cell skin cancer: We previously reported that increased expression of programmed death ligand 1 (PD-L1) in metastatic MCC lesions strongly correlates with a better clinical outcome.3 PD-L1 is an immunoinhibitory molecule that suppresses T cell activation.